Evidence map›Paper›PMID 29599889›Full record

ArticleThe Pan African medical journal2017

Evolution of HIV prevalence and behavioral factors among MSM in Togo between 2011 and 2015.

Julienne Noude Teclessou, Séfako Abla Akakpo, Koumavi Didier Ekouevi, Georges Koumagnanou, Assétina Singo-Tokofai, Palokinam Vincent Pitche

Open access · goldAbstract read
In one paragraph

Article in The Pan African medical journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 3 pooled it
0.5field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 3 syntheses or guidelines pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 4 countries.

Julienne Noude TeclessouService of Dermato-Venerology, CHU Sylvanus Olympio, Unversity of Lome, Togo.
Séfako Abla AkakpoService of Dermato-Venerology, CHU Sylvanus Olympio, Unversity of Lome, Togo.
Koumavi Didier EkoueviPublic Health Department, University of Lomé, Togo.
Georges KoumagnanouPopulation Service International, Washington, US.
Assétina Singo-TokofaiNational AIDS Program, Ministry of Health, Saudi Arabia.
Palokinam Vincent PitcheService of Dermato-Venerology, CHU Sylvanus Olympio, Unversity of Lome, Togo.
Centre Hospitalier Universitaire de Tokoin · TGMinistry of Health · KWNational AIDS Council · ZWPopulation Services International · USUniversity of Lomé · TG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe aim of this study was to assess sexual behavior and measure HIV prevalence among MSM in 2015, in Togo.

methodsWe conducted a cross-sectional study from February to March 2015 in nine major cities of Togo. The respondent-driven sampling method was used to recruit MSM. Behavioral data were collected by interviewer-administered questionnaires. The blood tests were then carried out among MSM to assess their HIV status. Data were inputted into an Epidata database and exported to STATA

resultsA total of 496 MSM were involved in this study, with 43.35% in the capital, Lome. Over the past 12 months, 88.9% of MSM had had sexual intercourse with men and 24.1% of them had had sex with women. The last sexual intercourse was with a casual partner among 52.9% of MSM. During the last 30 days preceding the survey, 68.5% of MSM had regularly used a condom during active anal intercourse and 71.9% had used it during passive anal intercourse. The national prevalence rate of HIV among MSM was 13.0%. The factors associated with HIV infection were age of MSM OR = 5.30 [1.85-15.1], HIV testing history OR = 2.63 [1.18-5.87] and the city of residence of MSM OR = 5.56 [2.90-10.64].

conclusionThis study confirms that HIV prevalence among MSM is five times higher than in the general population (13% vs 2.5%). Thus, the need to rethink HIV sensitization and prevention strategies targeting hidden and stigmatized populations such as MSM.

Indexed as

Homosexuality, MaleAdultCondomsCross-Sectional StudiesHIV InfectionsHumansMalePrevalenceSexual BehaviorSexual PartnersSurveys and QuestionnairesTogoYoung Adultbehavioral MSMHIVTogo

Identifiers

PMID29599889
PMCPMC5873283
OpenAlexW2766653154

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.